Detalhe da pesquisa
1.
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials.
Eur Urol;
2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777647
2.
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.
medRxiv;
2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38766261
3.
Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting.
PLoS One;
19(4): e0301989, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683764
4.
ArCH: improving the performance of clonal hematopoiesis variant calling and interpretation.
Bioinformatics;
40(4)2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485690
5.
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.
Cancer Epidemiol Biomarkers Prev;
33(3): 419-425, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189661
6.
SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis.
Carcinogenesis;
45(1-2): 35-44, 2024 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856781
7.
Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification.
J Urol;
211(3): 415-425, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147400
8.
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States.
Cancer Res Commun;
4(1): 55-64, 2024 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108490
9.
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Qual Life Res;
32(11): 3209-3221, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410340
10.
Experience with the US health care system for Black and White patients with advanced prostate cancer.
Cancer;
129(16): 2532-2541, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246339
11.
IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer.
JCO Glob Oncol;
8: e2200154, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332173
12.
Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer.
Mol Oncol;
16(22): 3994-4010, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087093
13.
Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?
Cancer Prev Res (Phila);
15(12): 815-825, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125434
14.
The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer.
Clin Cancer Res;
28(16): 3603-3617, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35670774
15.
Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.
Prostate;
82(11): 1107-1116, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538298
16.
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress.
Proc Natl Acad Sci U S A;
119(3)2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031563
17.
Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors.
Clin Cancer Res;
28(2): 318-326, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667026
18.
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.
Mol Oncol;
16(13): 2451-2469, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792282
19.
Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.
Oncogene;
41(5): 671-682, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34802033
20.
Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.
Elife;
102021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34939926